Effects of intravitreal anti-VEGF therapy of kidney function in patients treated for proliferative diabetic retinopathy

views comments

Policy

Dr Ashley Neiweem discusses the effects of intravitreal anti-VEGF (vascular endothelial growth factor) on kidney function in patients with proliferative diabetic retinopathy.

Tags

Effects of intravitreal anti-VEGF therapy of kidney function in patients treated for proliferative diabetic retinopathy

Policy

Related Media